Drug Tariffs Are a Sideshow. Trump’s Next Move Could Hit Pharma Harder.
NegativeFinancial Markets

Investors are feeling uneasy as uncertainty looms over drug pricing, especially with Trump's potential next moves that could significantly impact the pharmaceutical industry. This situation is crucial because it highlights the ongoing debate about drug tariffs and their real implications for healthcare costs and access.
— Curated by the World Pulse Now AI Editorial System